Skip to main content
. 2007 Oct 6;22(12):1695–1703. doi: 10.1007/s11606-007-0399-6

Table 2.

Clinical and Laboratory Baseline Characteristics of the Patients

Characteristics* Intervention Group (n = 169) Control Group (n = 166)
Age (years) 55.7 ± 5.7 55.7 ± 5.6
Males (%) 41.4 42.2
Non-smoking (%) 78.1 78.3
Education level (%):
University 7.1 3.0
Secondary school 14.2 17.5
Primary school 78.7 79.5
Leisure physical activity (metabolic equivalent of the activity—hr/week) 18.9 ± 13.3 18.1 ± 16.0
Alcohol (g/day) 15.9 ± 23.6 16.5 ± 23.2
Height (m) 1.65 ± 9.9 1.65 ± 9.6
Weight (kg) 81.7 ± 14.9 81.3 ± 13.5
Waist (cm) 99.6 ± 11.6 99.8 ± 10.6
BMI (kg/m2) 29.7 ± 4.1 29.8 ± 4.6
Systolic pressure (mmHg) 142.6 ± 14.1 141.5 ± 15.2
Diastolic pressure (mmHg) 88.2 ± 8.8 87.8 ± 9.5
Fasting glucose (mmol/L) 5.8 ± 0.8 5.8 ± 0.7
Total cholesterol (mmol/L) 5.8 ± 1.1 6.0 ± 1.1
HDL-cholesterol (mmol/L) 1.4 ± 0.3 1.4 ± 0.3
Triglycerides (mmol/L) 1.9 (0.9) 1.9 (0.9)
Fasting insulin (pmol/L) 20.4 (24.0) 21.3 (31.2)
Homeostasis-Model-Assessment score for Insulin Resistance (mmol/L×μU/mL) 0.81 (1.11) 0.84 (1.33)
Hs-CRP (mg/L) 3.50 (4.60) 3.10 (3.60)
Uric acid (μmol/L) 216.7 ± 56.3 223.6 ± 59.5
Metabolic syndrome (%) 70.4 72.3
Hs-CRP ≥ 3 mg/L (%) 56.2 50.6
No components of the metabolic syndrome
2 29.6 27.7
3 56.2 60.2
≥ 4 14.2 12.1
Taking antihypertensive drugs (%) 36.1 33.7
Taking statin/fibrates (%) 6.5 6.0

All data are complete.

BMI=body mass index; hs-CRP=high-sensitivity C-reactive protein

*If not otherwise specified, data are reported as means (± standard deviation)

Median ± inter-quartile range for not normally distributed values

‡The metabolic syndrome was defined in the presence of ≥3 of the following five criteria: fasting glucose ≥6.1 mmol/L; blood pressure ≥130/85 mmHg; triglycerides ≥1.69 mmol/L; HDL cholesterol <1.29 mmol/L (females) or <1.04 mmol/L (males) and waist circumference >88 cm (females) or >102 cm (males)8.